Questcor short seller releases additional Acthar Gel lab data Citron Research reports on analysis of Questcor's ( QCOR -0.8% ) Acthar. It alleges the product is not porcine deamidated corticotrophin, the amino acid sequence is different than the sequence described in the product's package insert and the actual concentration of deamidated corticotrophin is much lower than the claimed 80IU/ml. The FDA is reviewing the lab tests . 7 comments!
March 14, 2014 - Seeking Alpha